Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David A. Parry is active.

Publication


Featured researches published by David A. Parry.


American Journal of Human Genetics | 2009

Null mutations in LTBP2 cause primary congenital glaucoma

Manir Ali; Martin McKibbin; Adam D. Booth; David A. Parry; Payal Jain; S. Amer Riazuddin; J. Fielding Hejtmancik; Shaheen N. Khan; Sabika Firasat; Mike Shires; David F. Gilmour; Katherine V. Towns; Anna Louise Murphy; Dimitar N. Azmanov; Ivailo Tournev; Sylvia Cherninkova; Hussain Jafri; Yasmin Raashid; Carmel Toomes; Jamie E. Craig; David A. Mackey; Luba Kalaydjieva; Sheikh Riazuddin; Chris F. Inglehearn

Primary congenital glaucoma (PCG) is an autosomal-recessive condition characterized by high intraocular pressure (IOP), usually within the first year of life, which potentially could lead to optic nerve damage, globe enlargement, and permanent loss of vision. To date, PCG has been linked to three loci: 2p21 (GLC3A), for which the responsible gene is CYP1B1, and 1p36 (GLC3B) and 14q24 (GLC3C), for which the genes remain to be identified. Here we report that null mutations in LTBP2 cause PCG in four consanguineous families from Pakistan and in patients of Gypsy ethnicity. LTBP2 maps to chromosome 14q24.3 but is around 1.3 Mb proximal to the documented GLC3C locus. Therefore, it remains to be determined whether LTBP2 is the GLC3C gene or whether a second adjacent gene is also implicated in PCG. LTBP2 is the largest member of the latent transforming growth factor (TGF)-beta binding protein family, which are extracellular matrix proteins with multidomain structure. It has homology to fibrillins and may have roles in cell adhesion and as a structural component of microfibrils. We confirmed localization of LTBP2 in the anterior segment of the eye, at the ciliary body, and particularly the ciliary process. These findings reveal that LTBP2 is essential for normal development of the anterior chamber of the eye, where it may have a structural role in maintaining ciliary muscle tone.


Nature Genetics | 2014

Loss-of-function mutations in MICU1 cause a brain and muscle disorder linked to primary alterations in mitochondrial calcium signaling

Clare V. Logan; Gyorgy Szabadkai; Jenny A. Sharpe; David A. Parry; Silvia Torelli; Anne-Marie Childs; Marjolein Kriek; Rahul Phadke; Colin A. Johnson; Nicola Roberts; David T. Bonthron; Karen A. Pysden; Tamieka Whyte; Iulia Munteanu; A. Reghan Foley; Gabrielle Wheway; Katarzyna Szymanska; Subaashini Natarajan; Zakia Abdelhamed; J.E. Morgan; Helen Roper; Gijs W.E. Santen; Erik H. Niks; W. Ludo van der Pol; Dick Lindhout; Anna Raffaello; Diego De Stefani; Johan T. den Dunnen; Yu Sun; Ieke B. Ginjaar

Mitochondrial Ca2+ uptake has key roles in cell life and death. Physiological Ca2+ signaling regulates aerobic metabolism, whereas pathological Ca2+ overload triggers cell death. Mitochondrial Ca2+ uptake is mediated by the Ca2+ uniporter complex in the inner mitochondrial membrane, which comprises MCU, a Ca2+-selective ion channel, and its regulator, MICU1. Here we report mutations of MICU1 in individuals with a disease phenotype characterized by proximal myopathy, learning difficulties and a progressive extrapyramidal movement disorder. In fibroblasts from subjects with MICU1 mutations, agonist-induced mitochondrial Ca2+ uptake at low cytosolic Ca2+ concentrations was increased, and cytosolic Ca2+ signals were reduced. Although resting mitochondrial membrane potential was unchanged in MICU1-deficient cells, the mitochondrial network was severely fragmented. Whereas the pathophysiology of muscular dystrophy and the core myopathies involves abnormal mitochondrial Ca2+ handling, the phenotype associated with MICU1 deficiency is caused by a primary defect in mitochondrial Ca2+ signaling, demonstrating the crucial role of mitochondrial Ca2+ uptake in humans.


American Journal of Human Genetics | 2011

Mutations Causing Familial Biparental Hydatidiform Mole Implicate C6orf221 as a Possible Regulator of Genomic Imprinting in the Human Oocyte

David A. Parry; Clare V. Logan; Bruce E. Hayward; Michael Shires; Hanène Landolsi; Christine P. Diggle; Ian M. Carr; Cécile Rittore; Isabelle Touitou; Laurent Philibert; Rosemary A. Fisher; Masoumeh Fallahian; John Huntriss; Helen M. Picton; Saghira Malik; Graham R. Taylor; Colin A. Johnson; David T. Bonthron; Eamonn Sheridan

Familial biparental hydatidiform mole (FBHM) is the only known pure maternal-effect recessive inherited disorder in humans. Affected women, although developmentally normal themselves, suffer repeated pregnancy loss because of the development of the conceptus into a complete hydatidiform mole in which extraembryonic trophoblastic tissue develops but the embryo itself suffers early demise. This developmental phenotype results from a genome-wide failure to correctly specify or maintain a maternal epigenotype at imprinted loci. Most cases of FBHM result from mutations of NLRP7, but genetic heterogeneity has been demonstrated. Here, we report biallelic mutations of C6orf221 in three families with FBHM. The previously described biological properties of their respective gene families suggest that NLRP7 and C6orf221 may interact as components of an oocyte complex that is directly or indirectly required for determination of epigenetic status on the oocyte genome.


Nature Genetics | 2012

Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degeneration

Robert K. Koenekoop; Hui Wang; Jacek Majewski; Xia Wang; Irma Lopez; Huanan Ren; Yiyun Chen; Yumei Li; Gerald A. Fishman; Mohammed Genead; Jeremy Schwartzentruber; Naimesh Solanki; Elias I. Traboulsi; Jingliang Cheng; Clare V. Logan; Martin McKibbin; Bruce E. Hayward; David A. Parry; Colin A. Johnson; Mohammed Nageeb; James A. Poulter; Moin D. Mohamed; Hussain Jafri; Yasmin Rashid; Graham R. Taylor; Vafa Keser; Graeme Mardon; Huidan Xu; Chris F. Inglehearn; Qing Fu

Leber congenital amaurosis (LCA) is a blinding retinal disease that presents within the first year after birth. Using exome sequencing, we identified mutations in the nicotinamide adenine dinucleotide (NAD) synthase gene NMNAT1 encoding nicotinamide mononucleotide adenylyltransferase 1 in eight families with LCA, including the family in which LCA was originally linked to the LCA9 locus. Notably, all individuals with NMNAT1 mutations also have macular colobomas, which are severe degenerative entities of the central retina (fovea) devoid of tissue and photoreceptors. Functional assays of the proteins encoded by the mutant alleles identified in our study showed that the mutations reduce the enzymatic activity of NMNAT1 in NAD biosynthesis and affect protein folding. Of note, recent characterization of the slow Wallerian degeneration (Wlds) mouse model, in which prolonged axonal survival after injury is observed, identified NMNAT1 as a neuroprotective protein when ectopically expressed. Our findings identify a new disease mechanism underlying LCA and provide the first link between endogenous NMNAT1 dysfunction and a human nervous system disorder.


Nature Genetics | 2014

Mutations in TJP2 cause progressive cholestatic liver disease

Melissa Sambrotta; Sandra Strautnieks; Efterpi Papouli; Peter Rushton; Barnaby Clark; David A. Parry; Clare V. Logan; Lucy J. Newbury; Binita M. Kamath; Simon C. Ling; Tassos Grammatikopoulos; Bart Wagner; John C. Magee; Ronald J. Sokol; Giorgina Mieli-Vergani; Joshua D. Smith; Colin A. Johnson; Patricia McClean; Michael A. Simpson; A.S. Knisely; Laura N. Bull; Richard Thompson

Elucidating genetic causes of cholestasis has proved to be important in understanding the physiology and pathophysiology of the liver. Here we show that protein-truncating mutations in the tight junction protein 2 gene (TJP2) cause failure of protein localization and disruption of tight-junction structure, leading to severe cholestatic liver disease. These findings contrast with those in the embryonic-lethal knockout mouse, highlighting differences in redundancy in junctional complexes between organs and species.


American Journal of Human Genetics | 2009

Mutations in CNNM4 Cause Jalili Syndrome, Consisting of Autosomal-Recessive Cone-Rod Dystrophy and Amelogenesis Imperfecta

David A. Parry; Alan J. Mighell; Walid El-Sayed; R.C. Shore; I. K. Jalili; Hélène Dollfus; Agnes Bloch-Zupan; Roman Carlos; Ian M. Carr; Louise Downey; Katharine M. Blain; David Mansfield; Mehdi Shahrabi; Mansour Heidari; Parissa Aref; Mohsen Abbasi; Michel Michaelides; Anthony T. Moore; Jennifer Kirkham; Chris F. Inglehearn

The combination of recessively inherited cone-rod dystrophy (CRD) and amelogenesis imperfecta (AI) was first reported by Jalili and Smith in 1988 in a family subsequently linked to a locus on chromosome 2q11, and it has since been reported in a second small family. We have identified five further ethnically diverse families cosegregating CRD and AI. Phenotypic characterization of teeth and visual function in the published and new families reveals a consistent syndrome in all seven families, and all link or are consistent with linkage to 2q11, confirming the existence of a genetically homogenous condition that we now propose to call Jalili syndrome. Using a positional-candidate approach, we have identified mutations in the CNNM4 gene, encoding a putative metal transporter, accounting for the condition in all seven families. Nine mutations are described in all, three missense, three terminations, two large deletions, and a single base insertion. We confirmed expression of Cnnm4 in the neural retina and in ameloblasts in the developing tooth, suggesting a hitherto unknown connection between tooth biomineralization and retinal function. The identification of CNNM4 as the causative gene for Jalili syndrome, characterized by syndromic CRD with AI, has the potential to provide new insights into the roles of metal transport in visual function and biomineralization.


American Journal of Human Genetics | 2009

Mutations in the Beta Propeller WDR72 Cause Autosomal-Recessive Hypomaturation Amelogenesis Imperfecta

Walid El-Sayed; David A. Parry; R.C. Shore; Mushtaq Ahmed; Hussain Jafri; Yasmin Rashid; Suhaila Al-Bahlani; Sharifa Al Harasi; Jennifer Kirkham; Chris F. Inglehearn; Alan J. Mighell

Healthy dental enamel is the hardest and most highly mineralized human tissue. Though acellular, nonvital, and without capacity for turnover or repair, it can nevertheless last a lifetime. Amelogenesis imperfecta (AI) is a collective term for failure of normal enamel development, covering diverse clinical phenotypes that typically show Mendelian inheritance patterns. One subset, known as hypomaturation AI, is characterised by near-normal volumes of organic enamel matrix but with weak, creamy-brown opaque enamel that fails prematurely after tooth eruption. Mutations in genes critical to enamel matrix formation have been documented, but current understanding of other key events in enamel biomineralization is limited. We investigated autosomal-recessive hypomaturation AI in a consanguineous Pakistani family. A whole-genome SNP autozygosity screen identified a locus on chromosome 15q21.3. Sequencing candidate genes revealed a point mutation in the poorly characterized WDR72 gene. Screening of WDR72 in a panel of nine additional hypomaturation AI families revealed the same mutation in a second, apparently unrelated, Pakistani family and two further nonsense mutations in Omani families. Immunohistochemistry confirmed intracellular localization in maturation-stage ameloblasts. WDR72 function is unknown, but as a putative β propeller is expected to be a scaffold for protein-protein interactions. The nearest homolog, WDR7, is involved in vesicle mobilization and Ca2+-dependent exocytosis at synapses. Vesicle trafficking is important in maturation-stage ameloblasts with respect to secretion into immature enamel and removal of cleaved enamel matrix proteins via endocytosis. This raises the intriguing possibility that WDR72 is critical to ameloblast vesicle turnover during enamel maturation.


Science Translational Medicine | 2016

Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation

Seth L. Masters; Vasiliki Lagou; Isabelle Jéru; Paul J. Baker; Lien Van Eyck; David A. Parry; Dylan Lawless; Dominic De Nardo; Josselyn E. Garcia-Perez; Laura F. Dagley; Caroline L. Holley; James Dooley; Fiona Moghaddas; Emanuela Pasciuto; Pierre-Yves Jeandel; Raf Sciot; Dena Lyras; Andrew I. Webb; Sandra E. Nicholson; Lien De Somer; Erika Van Nieuwenhove; Julia Ruuth-Praz; Bruno Copin; Emmanuelle Cochet; Myrna Medlej-Hashim; Andre Megarbane; Kate Schroder; Sinisa Savic; An Goris; Serge Amselem

A mutation in pyrin that disrupts regulation leads to autoinflammatory disease. Guarding inflammation The innate immune system is hard-wired to protect people from infection. However, mutations in these protective genes can lead to uncontrolled inflammation, resulting in autoinflammatory disease. Now, Masters et al. describe a family with an autoinflammatory disease caused by a previously unreported mutation in pyrin. This mutation disrupts pyrin regulation and mimics the effect of pathogen sensing by pyrin, leading to proinflammatory interleukin-1β (IL-1β) production. Indeed, targeting IL-1β resolved disease in one patient. These data suggest that pyrin is regulated through a guard-like mechanism, which guards against autoinflammation in humans. Pyrin responds to pathogen signals and loss of cellular homeostasis by forming an inflammasome complex that drives the cleavage and secretion of interleukin-1β (IL-1β). Mutations in the B30.2/SPRY domain cause pathogen-independent activation of pyrin and are responsible for the autoinflammatory disease familial Mediterranean fever (FMF). We studied a family with a dominantly inherited autoinflammatory disease, distinct from FMF, characterized by childhood-onset recurrent episodes of neutrophilic dermatosis, fever, elevated acute-phase reactants, arthralgia, and myalgia/myositis. The disease was caused by a mutation in MEFV, the gene encoding pyrin (S242R). The mutation results in the loss of a 14-3-3 binding motif at phosphorylated S242, which was not perturbed by FMF mutations in the B30.2/SPRY domain. However, loss of both S242 phosphorylation and 14-3-3 binding was observed for bacterial effectors that activate the pyrin inflammasome, such as Clostridium difficile toxin B (TcdB). The S242R mutation thus recapitulated the effect of pathogen sensing, triggering inflammasome activation and IL-1β production. Successful therapy targeting IL-1β has been initiated in one patient, resolving pyrin-associated autoinflammation with neutrophilic dermatosis. This disease provides evidence that a guard-like mechanism of pyrin regulation, originally identified for Nod-like receptors in plant innate immunity, also exists in humans.


Nature Cell Biology | 2015

An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes

Gabrielle Wheway; Miriam Schmidts; Dorus A. Mans; Katarzyna Szymanska; Thanh Minh T Nguyen; Hilary Racher; Ian G. Phelps; Grischa Toedt; Julie Kennedy; Kirsten A. Wunderlich; Nasrin Sorusch; Zakia Abdelhamed; Subaashini Natarajan; Warren Herridge; Jeroen van Reeuwijk; Nicola Horn; Karsten Boldt; David A. Parry; Stef J.F. Letteboer; Susanne Roosing; Matthew Adams; Sandra M. Bell; Jacquelyn Bond; Julie Higgins; Ewan E. Morrison; Darren C. Tomlinson; Gisela G. Slaats; Teunis J. P. van Dam; Lijia Huang; Kristin Kessler

Defects in primary cilium biogenesis underlie the ciliopathies, a growing group of genetic disorders. We describe a whole-genome siRNA-based reverse genetics screen for defects in biogenesis and/or maintenance of the primary cilium, obtaining a global resource. We identify 112 candidate ciliogenesis and ciliopathy genes, including 44 components of the ubiquitin–proteasome system, 12 G-protein-coupled receptors, and 3 pre-mRNA processing factors (PRPF6, PRPF8 and PRPF31) mutated in autosomal dominant retinitis pigmentosa. The PRPFs localize to the connecting cilium, and PRPF8- and PRPF31-mutated cells have ciliary defects. Combining the screen with exome sequencing data identified recessive mutations in PIBF1, also known as CEP90, and C21orf2, also known as LRRC76, as causes of the ciliopathies Joubert and Jeune syndromes. Biochemical approaches place C21orf2 within key ciliopathy-associated protein modules, offering an explanation for the skeletal and retinal involvement observed in individuals with C21orf2 variants. Our global, unbiased approaches provide insights into ciliogenesis complexity and identify roles for unanticipated pathways in human genetic disease.


American Journal of Human Genetics | 2012

Mutations in C4orf26, encoding a peptide with in vitro hydroxyapatite crystal nucleation and growth activity, cause amelogenesis imperfecta

David A. Parry; Steven J. Brookes; Clare V. Logan; James A. Poulter; Walid El-Sayed; Suhaila Al-Bahlani; Sharifa Al Harasi; Jihad Sayed; El Mostafa Raïf; R.C. Shore; Mayssoon Dashash; Martin J. Barron; J.E. Morgan; Ian M. Carr; Graham R. Taylor; Colin A. Johnson; Michael J. Aldred; Michael J. Dixon; J. Tim Wright; Jennifer Kirkham; Chris F. Inglehearn; Alan J. Mighell

Autozygosity mapping and clonal sequencing of an Omani family identified mutations in the uncharacterized gene, C4orf26, as a cause of recessive hypomineralized amelogenesis imperfecta (AI), a disease in which the formation of tooth enamel fails. Screening of a panel of 57 autosomal-recessive AI-affected families identified eight further families with loss-of-function mutations in C4orf26. C4orf26 encodes a putative extracellular matrix acidic phosphoprotein expressed in the enamel organ. A mineral nucleation assay showed that the proteins phosphorylated C terminus has the capacity to promote nucleation of hydroxyapatite, suggesting a possible function in enamel mineralization during amelogenesis.

Collaboration


Dive into the David A. Parry's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge